A medicament having inhibitory activity against NF-κB activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient:
wherein X represents a connecting group, A represents hydrogen atom or acetyl group, E represents an aryl group or a heteroaryl group, and ring X represents an arene or a heteroarene.
Inhibitors against the production and release of inflammatory cytokines
申请人:——
公开号:US20040259877A1
公开(公告)日:2004-12-23
A medicament having inhibitory activity against NF-&kgr;B activation, which comprises a compound represented by the following general formula (I) or a pharmacologically acceptable salt as an active ingredient:
1
wherein X represents a connecting group, A represents hydrogen atom or acetyl group, E represents an aryl group or a heteroaryl group, and ring X represents an arene or a heteroarene.
A medicament having inhibitory activity against plasminogen activator inhibitor-1, which comprises as an active ingredient a compound represented by the following general formula (I) or a salt thereof:
wherein R
1
and R
2
represents an aromatic group which may be substituted, W represents a group selected from the following connecting group W-1:
(wherein a bond at the left end binds to the carbon atom and a bond at the right end binds to the nitrogen atom, X represents sulfur atom or NH, Y represents oxygen atom or sulfur atom,
R
3
represents a hydrocarbon group, hydroxy group, or carboxy group),
Z represents a single bond or a connecting group wherein a number of atoms in a main chain is 1 to 3.